Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|April 21, 2010
Systemic therapies in metastatic non-small-cell lung cancer with emphasis on targeted therapies: the rational approachV HirshCurrent Oncology (Toronto, Ont.)|June 10, 2011
Managing treatment-related adverse events associated with egfr tyrosine kinase inhibitors in advanced non-small-cell lung cancerV HirshHuman Fertility (Cambridge, England)|February 15, 2002
Infertility in Jewish couples, biblical and rabbinic lawAnthony V. HirshHuman Reproduction Update|September 1, 1995
The anatomical preparations of the human testis and epididymis in the Glasgow Hunterian Anatomical CollectionA V HirshCurrent Oncology (Toronto, Ont.)|June 19, 2018
Irreversible tyrosine kinase inhibition of epidermal growth factor receptor with afatinib in EGFR activating mutation-positive advanced non-small-cell lung cancerS Morin-Ben Abdallah, V HirshCurrent Oncology (Toronto, Ont.)|April 20, 2012
A personalized approach to treatment: use of EGFR tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in CanadaV Hirsh, B Melosky, G Goss, et al.Current Oncology (Toronto, Ont.)|December 10, 2014
Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitorsV Hirsh, N Blais, R Burkes, et al.British Journal of Urology|December 1, 1980
Doppler flow studies, venography and thermography in the evaluation of varicoceles of fertile and subfertile menA V Hirsh, M J Kellett, G Robertson, et al.Nuclear Medicine Communications|September 1, 1989
Imaging of small cell carcinoma using 131I-labelled antibodies to vasopressin associated human neurophysin (VP-HNP)W G North, V Hirsh, R Lisbona, et al.Current Oncology (Toronto, Ont.)|March 12, 2019
Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancerP K Cheema, J Rothenstein, B Melosky, et al.Pageof 4